Top Companies in Membrane Oxygenators Market & Their Offerings
Bring clarity to your xxx Market strategy - Buy Now.
| Companies | Headquarters | Offerings |
| Medtronic | Dublin, Ireland | Provides membrane oxygenators, perfusion circuits, and extracorporeal life-support systems used in cardiac surgeries and ECMO procedures. |
| Fresenius SE & Co. KGaA | Bad Homburg, Germany | Offers advanced critical care and extracorporeal support solutions, including systems used for respiratory and cardiac failure management. |
| Getinge AB | Gothenburg, Sweden | Develops ECMO platforms, membrane oxygenators, and cardiopulmonary support devices for hospital and ICU applications. |
| TERUMO CORPORATION | Tokyo, Japan | Offers oxygenation systems for adult, pediatric, and neonatal procedures, along with perfusion and bypass solutions. |
| MicroPort Scientific Corporation | Shanghai, China | Provides cardiopulmonary support equipment and oxygenation technologies for surgical and intensive care use. |
| Nipro Medical Corporation | Osaka, Japan | Manufactures hollow fiber oxygenators and extracorporeal circulation products for critical care and cardiac procedures. |
| Kewei Medical | Dongguan, China | Focuses on membrane oxygenators and related life-support devices used in operating rooms and ICUs. |
What are the Recent Developments in the Membrane Oxygenators Market?
- In October 2025, Cooper University Health Care’s ECMO program was honored with ELSO’s Gold Level recognition, showcasing its excellence in advanced life-support services, innovative treatment approaches, and strong multidisciplinary care for patients facing severe cardiac and respiratory conditions.
- In April 2025, AdventHealth Orlando, in collaboration with Orange County, introduced an ECMO CPR program aimed at improving survival rates and neurological recovery in cardiac arrest cases. The program ensures continuous circulation and oxygen support during patient transport and is strengthened by advanced EMS training and the hospital’s extensive ECMO capabilities.
Supply Chain Analysis
R&D
- R&D in the membrane oxygenators market is centered on improving long-term blood compatibility, boosting oxygen and carbon dioxide exchange efficiency, and reducing priming volume, particularly for ECMO applications. Recent developments include advanced PMP materials and specially coated hollow fibers that help reduce plasma leakage and clot formation.
- Key Players: Medtronic, Terumo, Getinge, LivaNova, and Nipro.
Clinical Trials
- Clinical trials in the membrane oxygenators market are focused on improving blood compatibility, lowering priming volume, and enhancing gas exchange performance compared to conventional models. These studies aim to improve patient safety, reduce complications, and support better outcomes in ECMO and cardiac surgery procedures.
- Key players: Medtronic, Terumo, Getinge, LivaNova, and Nipro
Patient Support and Services
- Patient support and services for membrane oxygenators, especially in ECMO care, involve continuous round-the-clock assistance from a multidisciplinary team that includes perfusion specialists, ICU nurses, and physicians. Key services include real-time circuit monitoring, anticoagulation control, nutritional management, and rehabilitation support.
- Key players: Medtronic, Getinge, Terumo, Fresenius Medical Care, and Nipro.
Market Trends
The global membrane oxygenators market size was estimated at USD 1.45 billion in 2025 and is predicted to increase from USD 1.55 billion in 2026 to approximately USD 2.83 billion by 2035, expanding at a CAGR of 6.9% from 2026 to 2035. The market is expanding because of the growing need for advanced life-support devices in cardiac surgeries, emergency care, and severe respiratory treatment.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking